INTERNATIONAL PATENT: INNDURA THERAPEUTICS INC. FILES APPLICATION FOR "A MODIFIED IMMUNE CELL RECEPTOR COMPRISING A TARGET-BINDING DOMAIN AND THE EXTRACELLULAR DOMAIN OF CD16A"

GENEVA, Nov. 19 -- INNDURA THERAPEUTICS INC. (LabCentral, 700 Main StreetCambridge, Massachusetts 02139) filed a patent application (PCT/US2025/028598) for "A MODIFIED IMMUNE CELL RECEPTOR COMPRISING A TARGET-BINDING DOMAIN AND THE EXTRACELLULAR DOMAIN OF CD16A" on May 09, 2025. With publication no. WO/2025/235862, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): IVICA, Nikola (c/o InnDura Therapeutics Inc., LabCentral, 700 Main StreetCambridge, Massachusetts 02139), KOVACS, Istvan (c/o InnDura Therapeutics Inc., LabCentra...